• Free Express Shipping on Orders $200+
  • Get Premium-Grade Peptides and Save When You Buy in Bundles
  • Made in the USA

Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · capsules

Epic Peptides Lab · USA

Document number
PL-SDS-152
Revision
1.0 · 2026-10-03

SLU-PP-332

capsules

1Identification

Product Identifier
SLU-PP-332
Document Number
PL-SDS-152
Catalogue Items Covered
  • Id
    5096
    Name
    SLU-PP-332 (1000mcg) (30 Capsules)
    Sku
    PL-SLUPP332-1000MCG-CAP
Recommended Use
Laboratory research use by trained personnel.
Restrictions On Use
Not for human or veterinary use.
Supplier / Distributor
Epic Peptides Lab, USA
Telephone
+1 (787) 468-5291
Email
info@epicpeptideslab.com

2Hazard(s) identification

Classification
Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements
No data available.
Signal Word
No data available.
Other Hazards
No data available.

3Composition / information on ingredients

Description
Hard gelatin capsules containing the active substance blended with microcrystalline cellulose, packed in a sealed bottle.
Composition
  • Name
    SLU-PP-332
    Full
    4-hydroxy-N-[(Z)-naphthalen-2-ylmethylideneamino]benzamide; ERR agonist
    Cas
    303760-60-3
    Formula
    C18H14N2O2
    Conc
    as labelled
    Qty
    as labelled
    Hazards
    • Skin corrosion/irritation — Category 2 — H315
    • Serious eye damage/eye irritation — Category 2A — H319
  • Name
    Microcrystalline cellulose
    Full
    Microcrystalline cellulose (capsule filler)
    Cas
    9004-34-6
    Formula
    (C6H10O5)n
    Conc
    balance of capsule contents
  • Name
    Gelatin
    Full
    Gelatin (capsule shell)
    Cas
    9000-70-8
    Conc
    capsule shell

4First-aid measures

First Aid Measures
Inhalation
Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin
Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes
Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion
Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Most Important Symptoms And Effects
No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.
Likely Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.

5Fire-fighting measures

Fire Fighting Information
Combustible organic solid; capsule contents may form combustible dust if dispersed in bulk.

6Accidental release measures

Spill And Clean Up Procedures
Collect intact capsules. Dampen any spilled powder with water, wipe up with absorbent material and place in a sealed container for disposal.

7Handling and storage

Safe Handling
Do not open or crush capsules unless required for an experiment; if capsule contents are handled as a powder, avoid generating dust and weigh inside a ventilated enclosure. Wash hands after handling.
Safe Storage
Store at room temperature (15–25 °C) in the tightly closed original container, dry and protected from light.
Storage Temperature
15–25 °C, dry, protected from light
Incompatible Materials
Strong oxidizing agents; strong acids (hydrolysis); strong bases (phenol).

8Exposure controls / personal protection

Occupational Exposure Limits
  • Microcrystalline cellulose: OSHA PEL 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction); ACGIH TLV 10 mg/m³ (as cellulose).
  • No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE
No data available.

9Physical and chemical properties

Physical State
Solid
Appearance
Hard gelatin capsules containing a white to off-white powder
Properties
Odor
Characteristic (Cayman)
Ph
Not applicable (solid)
Melting
Undetermined (Cayman)
Boiling
Undetermined (Cayman)
Flash
Not applicable (non-flammable solid); combustible organic material
Vapour
Negligible (solid)
Density
No data available (bulk density of lyophilized cake is low)
Solubility
Ethanol: slightly soluble; DMSO: sparingly soluble (Cayman); TargetMol: DMSO 83.33 mg/mL (287 mM); water: not determined (expected poorly soluble)
Logp
Not in SDS (predicted logP ~3)
Decomp
No data available; peptides decompose above about 200 °C
Other
4-hydroxy-N'-[(naphthalen-2-yl)methylidene]benzohydrazide (N-acylhydrazone), C18H14N2O2, MW 290.3, CAS 303760-60-3; density 1.20 g/cm3 (predicted, TargetMol). Not flammable (Cayman).

10Stability and reactivity

Stability And Reactivity
Reactivity
No dangerous reactions known (Cayman). Hydrazone C=N bond is hydrolytically labile under acidic/aqueous conditions.
Incompatible
Strong oxidizing agents; strong acids (hydrolysis); strong bases (phenol).
Decomposition
No dangerous decomposition products known (Cayman); combustion gives carbon oxides and nitrogen oxides.
Conditions To Avoid
Heat, light, moisture, acids.
Conditions To Avoid
Heat, light, moisture, acids
Incompatible Materials
No data available.

11Toxicological information

Toxicological Information
  • Acute toxicity, oral

    No data available

  • Acute toxicity, dermal

    No data available

  • Acute toxicity, inhalation

    No data available

  • Skin corrosion/irritation

    Cayman: no irritant effect; TargetMol: Skin irritation Category 2 (H315)

  • Serious eye damage/irritation

    Cayman: no irritating effect; TargetMol: Eye irritation Category 2A (H319)

  • Respiratory or skin sensitisation

    No sensitizing effects known (Cayman); TargetMol: no data

  • Germ cell mutagenicity

    No data available (structural alert: aryl hydrazone/acylhydrazone - potential for hydrolysis to naphthaldehyde and 4-hydroxybenzohydrazide; hydrazides/hydrazones are a genotoxicity structural-alert class)

  • Carcinogenicity

    Not listed by IARC, NTP, OSHA (Cayman)

  • Reproductive toxicity

    No data available

  • STOT, single exposure

    No data available

  • STOT, repeated exposure

    No data available

  • Aspiration hazard

    No data available

Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.
Symptoms
No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information
Cayman: water hazard class 1 (self-assessment), slightly hazardous for water. TargetMol: no data. Poorly water-soluble aromatic hydrazone - no aquatic toxicity data.

13Disposal considerations

Disposal Guidance
No data available.

14Transport information

Transport Classification
Note
Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information
Tsca
Not listed on TSCA inventory (Cayman). R&D exemption applies.
Carcinogen Listings
Not listed by IARC, NTP, OSHA, California Prop 65.
Dea
Not a controlled substance.
Other
Not an approved drug; research compound only (sold illegally as 'exercise mimetic' supplement). WADA remark: same mechanistic class (metabolic modulators/exercise mimetics) as prohibited S4.4 substances; check the current WADA S4.4 list for explicit naming of SLU-PP-332 - remark only.
Carcinogen Listings
No data available.

16Other information

Revision
October 3, 2026
Sources Consulted
  • Cayman Chemical
  • TargetMol
  • Spectrum Chemical
  • Sigachi Industries
  • Parchem
  • Fisher Scientific / Acros Organics
  • Electron Microscopy Sciences
Confidence
medium
Additional Information
  • Acylhydrazone; estrogen-related receptor agonist. WADA Prohibited List class S4.4.
Back to SDS list
JOIN THE Epic Peptides Lab
Exclusive access for verified researchers only.

Enter your details to access our catalog, COA library,
and research compound database.

By submitting you agree to receive email communications from Epic Peptides Lab You can unsubscribe at any time. All products for in vitro research use only.

  • The Email Catalog
15% off any order

Restock alerts, new compounds and fresh lab results.
We’ll email your code straight away – 15% off, one-time use.

  • ≥99%
  • COA every batch
  • Ships from USA

Research updates only. Unsubscribe any time.